Cara Therapeutics | CARA - Devedores Comerciais





Devedores Comerciais Alterar Data
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Alterity Therapeutics Limited AUD 4.57M 1.42M 2025-12
Assertio Holdings USD 39.91M 2.7M 2024-06
Cara Therapeutics USD 2.24M 2.26M 2025-03
Cassava Sciences USD 120K 697K 2025-12
Chugai Pharma JPY 352.94B 90.17B 2026-03
Cipla INR 62.19B 12.42B 2026-03
Clal Biotechnology ILS 3.75M 186K 2022-12
Compugen USD 2.38M 448K 2025-12
CSL USD 4.32B 1.35B 2025-12
Grifols EUR 1B 285.88M 2025-12
Halozyme Therapeutics USD 457.99M 16.72M 2026-03
J&J USD 21.33B 3.72B 2025-12
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Pacira USD 125.64M 1.57M 2026-03
Pfizer USD 16.17B 332M 2026-03
RedHill Biopharma USD 280K 5.07M 2025-12
Supernus Pharmaceuticals USD 182.18M 5.62M 2026-03
Vanda Pharmaceuticals USD 47.1M 4.35M 2024-12